Patent: 6,306,423
✉ Email this page to a colleague
Summary for Patent: 6,306,423
Title: | Neurotoxin implant |
Abstract: | A biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years. The implant can be made of casting a solution of a polymer, such as an ethyl vinyl acetate copolymer and the neurotoxin. The neurotoxin can be a botulinum toxin. |
Inventor(s): | Donovan; Stephen (Capistrano Beach, CA), Brady; Daniel G. (San Juan Capistrano, CA) |
Assignee: | Allergan Sales, Inc. (Irvine, CA) |
Application Number: | 09/587,250 |
Patent Claims: | see list of patent claims |
Details for Patent 6,306,423
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |